- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
As the global economy mends, the 2021 growth of Sickle Cell Anemia Therapeutics will have significant change from previous year. According to our latest study, the global Sickle Cell Anemia Therapeutics market size is USD million in 2022 from USD 3271.3 million in 2021, with a change of % between 2021 and 2022. The global Sickle Cell Anemia Therapeutics market size will reach USD 9406.5 million in 2028, growing at a CAGR of 16.3% over the analysis period.
The United States Sickle Cell Anemia Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sickle Cell Anemia Therapeutics market, reaching US$ million by the year 2028. As for the Europe Sickle Cell Anemia Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sickle Cell Anemia Therapeutics players cover Emmaus Medical, Addmedica, Gamida Cell, and GlycoMimetics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sickle Cell Anemia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sickle Cell Anemia Therapeutics Market Size 2017-2028
2.1.2 Sickle Cell Anemia Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Sickle Cell Anemia Therapeutics Segment by Type
2.2.1 Blood Transfusion
2.2.2 Pharmacotherapy
2.2.3 Bone Marrow Transplant
2.3 Sickle Cell Anemia Therapeutics Market Size by Type
2.3.1 Sickle Cell Anemia Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Sickle Cell Anemia Therapeutics Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Sickle Cell Anemia Therapeutics Market Size by Application
2.5.1 Sickle Cell Anemia Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2022)
3 Sickle Cell Anemia Therapeutics Market Size by Player
3.1 Sickle Cell Anemia Therapeutics Market Size Market Share by Players
3.1.1 Global Sickle Cell Anemia Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Sickle Cell Anemia Therapeutics by Regions
4.1 Sickle Cell Anemia Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Sickle Cell Anemia Therapeutics Market Size Growth (2017-2022)
4.3 APAC Sickle Cell Anemia Therapeutics Market Size Growth (2017-2022)
4.4 Europe Sickle Cell Anemia Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
5.2 Americas Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
5.3 Americas Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022)
6.2 APAC Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
6.3 APAC Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics by Country (2017-2022)
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sickle Cell Anemia Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Sickle Cell Anemia Therapeutics Market Forecast
10.1 Global Sickle Cell Anemia Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Sickle Cell Anemia Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Sickle Cell Anemia Therapeutics Forecast
10.1.3 APAC Sickle Cell Anemia Therapeutics Forecast
10.1.4 Europe Sickle Cell Anemia Therapeutics Forecast
10.1.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast
10.2 Americas Sickle Cell Anemia Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Sickle Cell Anemia Therapeutics Market Forecast
10.2.2 Canada Sickle Cell Anemia Therapeutics Market Forecast
10.2.3 Mexico Sickle Cell Anemia Therapeutics Market Forecast
10.2.4 Brazil Sickle Cell Anemia Therapeutics Market Forecast
10.3 APAC Sickle Cell Anemia Therapeutics Forecast by Region (2023-2028)
10.3.1 China Sickle Cell Anemia Therapeutics Market Forecast
10.3.2 Japan Sickle Cell Anemia Therapeutics Market Forecast
10.3.3 Korea Sickle Cell Anemia Therapeutics Market Forecast
10.3.4 Southeast Asia Sickle Cell Anemia Therapeutics Market Forecast
10.3.5 India Sickle Cell Anemia Therapeutics Market Forecast
10.3.6 Australia Sickle Cell Anemia Therapeutics Market Forecast
10.4 Europe Sickle Cell Anemia Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Sickle Cell Anemia Therapeutics Market Forecast
10.4.2 France Sickle Cell Anemia Therapeutics Market Forecast
10.4.3 UK Sickle Cell Anemia Therapeutics Market Forecast
10.4.4 Italy Sickle Cell Anemia Therapeutics Market Forecast
10.4.5 Russia Sickle Cell Anemia Therapeutics Market Forecast
10.5 Middle East & Africa Sickle Cell Anemia Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Sickle Cell Anemia Therapeutics Market Forecast
10.5.2 South Africa Sickle Cell Anemia Therapeutics Market Forecast
10.5.3 Israel Sickle Cell Anemia Therapeutics Market Forecast
10.5.4 Turkey Sickle Cell Anemia Therapeutics Market Forecast
10.5.5 GCC Countries Sickle Cell Anemia Therapeutics Market Forecast
10.6 Global Sickle Cell Anemia Therapeutics Forecast by Type (2023-2028)
10.7 Global Sickle Cell Anemia Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Information
11.1.2 Emmaus Medical Sickle Cell Anemia Therapeutics Product Offered
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Emmaus Medical Main Business Overview
11.1.5 Emmaus Medical Latest Developments
11.2 Addmedica
11.2.1 Addmedica Company Information
11.2.2 Addmedica Sickle Cell Anemia Therapeutics Product Offered
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Addmedica Main Business Overview
11.2.5 Addmedica Latest Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Information
11.3.2 Gamida Cell Sickle Cell Anemia Therapeutics Product Offered
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gamida Cell Main Business Overview
11.3.5 Gamida Cell Latest Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Information
11.4.2 GlycoMimetics Sickle Cell Anemia Therapeutics Product Offered
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GlycoMimetics Main Business Overview
11.4.5 GlycoMimetics Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Sickle Cell Anemia Therapeutics Product Offered
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Sickle Cell Anemia Therapeutics Product Offered
11.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Information
11.7.2 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Global Blood Therapeutics Main Business Overview
11.7.5 Global Blood Therapeutics Latest Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Information
11.8.2 Micelle BioPharma Sickle Cell Anemia Therapeutics Product Offered
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Micelle BioPharma Main Business Overview
11.8.5 Micelle BioPharma Latest Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Information
11.9.2 Bluebird Bio Sickle Cell Anemia Therapeutics Product Offered
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bluebird Bio Main Business Overview
11.9.5 Bluebird Bio Latest Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Information
11.10.2 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Prolong Pharmaceuticals Main Business Overview
11.10.5 Prolong Pharmaceuticals Latest Developments
11. Modus Therapeutics
11.11.1 Modus Therapeutics Company Information
11.11.2 Modus Therapeutics Sickle Cell Anemia Therapeutics Product Offered
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Modus Therapeutics Main Business Overview
11.11.5 Modus Therapeutics Latest Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Information
11.12.2 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Offered
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Sangamo Biosciences Main Business Overview
11.12.5 Sangamo Biosciences Latest Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Information
11.13.2 Bioverativ Sickle Cell Anemia Therapeutics Product Offered
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Bioverativ Main Business Overview
11.13.5 Bioverativ Latest Developments
11.14 Imara
11.14.1 Imara Company Information
11.14.2 Imara Sickle Cell Anemia Therapeutics Product Offered
11.14.3 Imara Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Imara Main Business Overview
11.14.5 Imara Latest Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Information
11.15.2 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Ironwood Pharmaceuticals Main Business Overview
11.15.5 Ironwood Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Sickle Cell Anemia Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Blood Transfusion
Table 3. Major Players of Pharmacotherapy
Table 4. Major Players of Bone Marrow Transplant
Table 5. Sickle Cell Anemia Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Sickle Cell Anemia Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Sickle Cell Anemia Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
Table 14. Sickle Cell Anemia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sickle Cell Anemia Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Sickle Cell Anemia Therapeutics
Table 44. Key Market Challenges & Risks of Sickle Cell Anemia Therapeutics
Table 45. Key Industry Trends of Sickle Cell Anemia Therapeutics
Table 46. Global Sickle Cell Anemia Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Sickle Cell Anemia Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Sickle Cell Anemia Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Sickle Cell Anemia Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Sickle Cell Anemia Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Sickle Cell Anemia Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Emmaus Medical Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 53. Emmaus Medical Sickle Cell Anemia Therapeutics Product Offered
Table 54. Emmaus Medical Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Emmaus Medical Main Business
Table 56. Emmaus Medical Latest Developments
Table 57. Addmedica Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 58. Addmedica Sickle Cell Anemia Therapeutics Product Offered
Table 59. Addmedica Main Business
Table 60. Addmedica Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Addmedica Latest Developments
Table 62. Gamida Cell Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 63. Gamida Cell Sickle Cell Anemia Therapeutics Product Offered
Table 64. Gamida Cell Main Business
Table 65. Gamida Cell Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Gamida Cell Latest Developments
Table 67. GlycoMimetics Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 68. GlycoMimetics Sickle Cell Anemia Therapeutics Product Offered
Table 69. GlycoMimetics Main Business
Table 70. GlycoMimetics Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. GlycoMimetics Latest Developments
Table 72. Pfizer Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 73. Pfizer Sickle Cell Anemia Therapeutics Product Offered
Table 74. Pfizer Main Business
Table 75. Pfizer Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Pfizer Latest Developments
Table 77. Novartis Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 78. Novartis Sickle Cell Anemia Therapeutics Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Novartis Latest Developments
Table 82. Global Blood Therapeutics Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 83. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Offered
Table 84. Global Blood Therapeutics Main Business
Table 85. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Global Blood Therapeutics Latest Developments
Table 87. Micelle BioPharma Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 88. Micelle BioPharma Sickle Cell Anemia Therapeutics Product Offered
Table 89. Micelle BioPharma Main Business
Table 90. Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Micelle BioPharma Latest Developments
Table 92. Bluebird Bio Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 93. Bluebird Bio Sickle Cell Anemia Therapeutics Product Offered
Table 94. Bluebird Bio Main Business
Table 95. Bluebird Bio Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Bluebird Bio Latest Developments
Table 97. Prolong Pharmaceuticals Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 98. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
Table 99. Prolong Pharmaceuticals Main Business
Table 100. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Prolong Pharmaceuticals Latest Developments
Table 102. Modus Therapeutics Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 103. Modus Therapeutics Sickle Cell Anemia Therapeutics Product Offered
Table 104. Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Modus Therapeutics Main Business
Table 106. Modus Therapeutics Latest Developments
Table 107. Sangamo Biosciences Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 108. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Offered
Table 109. Sangamo Biosciences Main Business
Table 110. Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Sangamo Biosciences Latest Developments
Table 112. Bioverativ Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 113. Bioverativ Sickle Cell Anemia Therapeutics Product Offered
Table 114. Bioverativ Main Business
Table 115. Bioverativ Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Bioverativ Latest Developments
Table 117. Imara Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 118. Imara Sickle Cell Anemia Therapeutics Product Offered
Table 119. Imara Main Business
Table 120. Imara Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Imara Latest Developments
Table 122. Ironwood Pharmaceuticals Details, Company Type, Sickle Cell Anemia Therapeutics Area Served and Its Competitors
Table 123. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Offered
Table 124. Ironwood Pharmaceuticals Main Business
Table 125. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Ironwood Pharmaceuticals Latest Developments
List of Figures
Figure 1. Sickle Cell Anemia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2021
Figure 7. Sickle Cell Anemia Therapeutics in Child
Figure 8. Global Sickle Cell Anemia Therapeutics Market: Child (2017-2022) & ($ Millions)
Figure 9. Sickle Cell Anemia Therapeutics in Adult
Figure 10. Global Sickle Cell Anemia Therapeutics Market: Adult (2017-2022) & ($ Millions)
Figure 11. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Sickle Cell Anemia Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Sickle Cell Anemia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Sickle Cell Anemia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Sickle Cell Anemia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Sickle Cell Anemia Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Sickle Cell Anemia Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Sickle Cell Anemia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Sickle Cell Anemia Therapeutics Market Size 2023-2028 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
